Advanced glycation (AGEs)
Reads: Reduces sugar damage
You want them minimized: fewer AGEs mean suppler vessels and slower metabolic aging.
What this marker reads
Advanced glycation end-products — the sugar-damaged proteins that stiffen tissue and inflame the vessel wall.
No body publishes a range for this marker
No society, national study or large cohort publishes a reference interval for circulating advanced glycation end-products. Blood AGE testing is not one test — CML, pentosidine, MG-H1 and total fluorescent AGEs report on different scales — so no figure would be comparable to a laboratory report.
Your laboratory reads your result against its own assay, and this page does not do that for it. What is above is what a named body published and for whom; the machinery this marker reads is set out on its pathway page, and the formulas witnessed on it are below.
The machinery behind it
What raises this marker and what it goes on to move — each edge carried with its own study — is set out in full on its pathway page: Reduces sugar damage →
Formulas that modulate it
Each formula page names this pathway and carries the study behind its claim.
Build a combo from your panel
Open the bloodwork builder and select every marker your lab flagged — it covers the most machinery with the fewest formulas.